Cancer Research Cancer Research Funding Available  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 4330-4331, November 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Valeriote, F.
Right arrow Articles by Tolen, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Valeriote, F.
Right arrow Articles by Tolen, S.

Protection and Potentiation of Nitrogen Mustard Cytotoxicity by WR-27211

Frederick Valeriote2 and Sandra Tolen

Section of Cancer Biology, Department of Radiology, Washington University School of Medicine, St. Louis, Missouri 63110

The radioprotective agent WR-2721 was examined for its effects on modifying the cytotoxicity of HN2 against normal and tumor cells in the AKR mouse. Quantitation was carried out by the spleen colony assay for both normal hematopoietic stem cells and AKR leukemia cells. Protection from drug toxicity and normal cell cytotoxicity was noted. Potentiation of cytotoxicity to AKR leukemia was found.

1 This work was supported by Grant CA 24960 from the National Cancer Institute, Department of Health and Human Services.

2 To whom requests for reprints should be addressed at Section of Cancer Biology, Division of Radiation Oncology, Washington University School of Medicine, 4511 Forest Park Blvd, Room 405, St. Louis, Mo. 63108.

Received 3/29/82. Accepted 7/26/82.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
H. Shen, Z. J. Chen, J. T. Zilfou, E. Hopper, M. Murphy, and K. D. Tew
Binding of the Aminothiol WR-1065 to Transcription Factors Influences Cellular Response to Anticancer Drugs
J. Pharmacol. Exp. Ther., June 1, 2001; 297(3): 1067 - 1073.
[Abstract] [Full Text]


Home page
J Oncol Pharm PractHome page
M. Summerhayes
Review : Amifostine and other chemoprotective agents in cancer chemotherapy: A brief review
Journal of Oncology Pharmacy Practice, December 1, 1995; 1(4): 21 - 31.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.